Download
About Us
Support
العربية
Invest
Products
Pricing
Academy
Free Stocks
Hot
Trading
Sahm ID
My Account
Log Out
Sign up / Log in
Open Account
Open Account
Home
News
Detail
Benchmark Upgrades NeoGenomics to Buy, Announces $11 Price Target
Like
Facebook
Twitter
Email
Link
Share
Facebook
Twitter
Email
Link
Cancel
Neogenomics
Neogenomics
NEO
0.00
0.00%
Benchmark analyst Bruce Jackson upgrades NeoGenomics (NASDAQ:
NEO
) from Hold to Buy and announces $11 price target.
Like
Unlike
Share
Share
Facebook
Twitter
Email
Link
Cancel